Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38101433

Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2024 Jan
First author
Grande E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Jan;25(1):2-3. doi: 10.1016/S1470-2045(23)00633-2.
    note
    Source null
    related pmid
    38101432
    relationship
    Comment in

Authors and identifiers

  1. name
    Grande E
    type
    Author
  2. name
    Arranz JÁ
    type
    Author
  3. name
    De Santis M
    type
    Author
  4. name
    Bamias A
    type
    Author
  5. name
    Kikuchi E
    type
    Author
  6. name
    Del Muro XG
    type
    Author
  7. name
    Park SH
    type
    Author
  8. name
    De Giorgi U
    type
    Author
  9. name
    Alekseev B
    type
    Author
  10. name
    Mencinger M
    type
    Author
  11. name
    Izumi K
    type
    Author
  12. name
    Schutz FA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Grande E
    type
    Author
  2. name
    Arranz JÁ
    type
    Author
  3. name
    De Santis M
    type
    Author
  4. name
    Bamias A
    type
    Author
  5. name
    Kikuchi E
    type
    Author
  6. name
    Del Muro XG
    type
    Author
  7. name
    Park SH
    type
    Author
  8. name
    De Giorgi U
    type
    Author
  9. name
    Alekseev B
    type
    Author
  10. name
    Mencinger M
    type
    Author
  11. name
    Izumi K
    type
    Author
  12. name
    Schutz FA
    type
    Author
bibliography ids
  1. nci-bib-cfb280064cd92b03432f7ef1
book metadata
content sha256
96b544599cff7bd42331c52bdd8f80655e4d0321b203ef34ad832580c7f8044d
document type
citation
dois
  1. 10.1016/S1470-2045(23)00540-5
electronic publication date
display
2023 Dec 12
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38101433
immutable id
pubmed:38101433@96b544599cff7bd42331c52bdd8f80655e4d0321b203ef34ad832580c7f8044d
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
29-45
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Jan;25(1):2-3. doi: 10.1016/S1470-2045(23)00633-2.
    note
    Source null
    related pmid
    38101432
    relationship
    Comment in
outcomes validated
false
pmid
38101433
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
0f1408a3dbd4c42a81116ffb2fc16fffd0404ca01e0a44fbd635a4b9b932959a
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan
precision
month
year
2024
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38101433/
title
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.

Preserved source evidence · Not medical advice